CVA Family Office, LLC

Family Office

Position in ELAN — Elanco Animal Health Inc

CIK 1802084 DENVER, CO

Position in ELAN

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$16,734

-$1,979 QoQ

Shares Held

680

-13.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#407

of 515 holders

Holding Since

Mar 2021

11 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

CVA Family Office, LLC holds $193,049 across 16 Drug Manufacturers - Specialty & Generic names. ELAN ranks #4 (8.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VTRS	Viatris Inc	4,734	$75,175
2	UTHR	UNITED THERAPEUTICS Corp	67	$36,302
3	NBIX	Neurocrine Biosciences Inc	103	$17,359
4	ELAN	Elanco Animal Health Inc This page	680	$16,734
5	ZTS	Zoetis Inc.	214	$15,378
6	ALKS	Alkermes plc.	159	$8,331
7	LNTH	Lantheus Holdings, Inc.	65	$7,211
8	AMRX	Amneal Pharmaceuticals, Inc.	260	$4,500

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$16,734	680	-13.0%	Shares	Sole	2026-08-07
2026-03-31	$18,713	782	+915.6%	Shares	Sole	2026-04-29
2025-12-31	$1,742	77	0.0%	Shares	Sole	2026-01-12
2025-09-30	$1,550	77	0.0%	Shares	Sole	2025-10-30
2025-06-30	$1,099	77	+54.0%	Shares	Sole	2025-07-31
2025-03-31	$525	50	+35.1%	Shares	Sole	2025-04-16
2024-06-30	$533	37	-90.8%	Shares	Sole	2024-07-10
2023-03-31	$3,760	400	+105.1%	Shares	Sole	2023-04-27
2022-09-30	$2,419	195	+34.5%	Shares	Sole	2022-11-22
2021-12-31	$4,115	145	-27.5%	Shares	Sole	2022-01-25
2021-03-31	$5,890	200	—	Shares	Sole	2021-04-14
No filing history on record for this holder in this stock.